Drug for further processing · DRUG FOR FURTHER PROCESSING
Alendronate Sodium NDC 60723-205
Alendronate sodium 70 mg/1 · Tablet · Hangzhou Minsheng Binjiang Pharmaceutical Co., Ltd
Unfinished product
This listing is a drug for further processing, not a finished drug product dispensed or administered to patients. It is not normally billed.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 60723-205-01 | 60723020501 | 1 BAG in 1 CASE (60723-205-01) / 40000 TABLET in 1 BAGMarketed from 25-JAN-18 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Generic name (nonproprietary)
- alendronate sodium
- Active ingredients
- Alendronate sodium — 70 mg/1
- Dosage form
- Tablet
- Product type
- Drug for further processing
- Marketing category
- Drug for further processing
- Marketing start
- Listing expires
- Identifiers
- Product ID 60723-205_48542b74-bd97-9af7-e063-6294a90a8bc1SPL ID 48542b74-bd97-9af7-e063-6294a90a8bc1
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- NDC on a medical claim
N460723020501followed by a unit qualifier and the quantityPackage 60723-0205-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
The FDA listing for this product does not reference a label (SPL) set.